李莎莎,马彩娜,杨金平,朱紫祥

• 1:西北民族大学生命科学与工程学院
• 2:中国农业科学院兰州兽医研究所家畜疫病病原学国家重点实验室/口蹄疫国家参考实验室

摘要(Abstract)：

为阐明更多非洲猪瘟病毒(African swine fever virus, ASFV)未知基因的功能，深入探究ASFV的致病机制，为研制针对ASFV流行毒株的疫苗提供候选毒株。采用同源重组的方法构建E184L基因缺失的非洲猪瘟单基因缺失毒株，在猪肺泡巨噬细胞(porcine alveolar macrophages, PAMs)中评价其复制特性，并在猪体内比较ASFVΔE184L与亲本毒株ASFV CN/GS/2018对猪的致病力以及在动物体内诱导免疫应答的差异。成功获得了E184L单基因缺失突变毒株ASFVΔE184L,经PCR鉴定、荧光观察及测序鉴定，证实该毒株E184L基因被成功缺失。复制特性研究发现，E184L基因的缺失削弱了ASFV在PAMs中的复制能力。动物体内试验显示，ASFVΔE184L接种猪在观察期内死亡1头，其余全部存活，而ASFV WT接种猪全部死亡，说明E184L的缺失导致ASFV的毒力显著下降。此外，与亲本毒株相比，ASFVΔE184L可诱导机体ASFV特异性抗体的产生及抗病毒因子干扰素β(interferon-β,IFN-β)的分泌。E184L为ASFV毒力相关基因及免疫抑制相关基因，其基因缺失毒株在猪体内的致病力显著减弱并能诱导机体内更强的免疫应答。以上结果为ASFV未知基因功能及其致病机制的阐明提供了新的理论依据，更重要的是，为在候选疫苗基因组中进一步缺失E184L基因片段构建安全有效的双基因或多基因缺失候选疫苗株奠定了重要基础。

关键词(KeyWords)： 非洲猪瘟病毒;E184L;毒力;免疫抑制;基因缺失;疫苗

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划资助项目(2021YFD1801300,2021YFD1800100);; 国家自然科学基金资助项目(31941002)

作者(Author): 李莎莎,马彩娜,杨金平,朱紫祥

DOI: 10.16303/j.cnki.1005-4545.2023.12.01

参考文献(References)：

• [1] GAUDREAULT N N,MADDEN D W,WILSON W C,et al.African swine fever virus:An emerging DNA arbovirus[J].Front Vet Sci,2020,7:215.
• [2] SALGUERO F J.Comparative pathology and pathogenesis of African swine fever infection in swine[J].Front Vet Sci,2020,7:282.
• [3] ZHOU X,LI N,LUO Y,et al.Emergence of African swine fever in China,2018[J].Transbound Emerg Dis,2018,65(6):1482-1484.
• [4] ZHAO D,LIU R,ZHANG X,et al.Replication and virulence in pigs of the first African swine fever virus isolated in China[J].Emerg Microbes Infect,2019,8(1):438-447.
• [5] QUEMBO C J,JORI F,VOSLOO W,et al.Genetic characterization of African swine fever virus isolates from soft ticks at the wildlife/domestic interface in Mozambique and identification of a novel genotype[J].Transbound Emerg Dis,2018,65(2):420-431.
• [6] REVILLA Y,PéREZ-NúEZ D,RICHT J A.African swine fever virus biology and vaccine approaches - Science Direct[J].Adv Virus Res,2018,100:41-74.
• [7] DIXON L K,CHAPMAN D,NETHERTON C L,et al.African swine fever virus replication and genomics[J].Virus Res,2013,173(1):3-14.
• [8] 扈荣良，于婉琪，陈腾.非洲猪瘟及防控技术研究现状[J].中国兽医学报，2019,39(2):13:357-369.
• [9] LEWIS T,ZSAK L,BURRAGE T G,et al.An African swine fever virus ERV1-ALR homologue,9GL,affects virion maturation and viral growth in macrophages and viral virulence in swine[J].J Virol,2000,74(3):1275-85.
• [10] TEKLUE T,WANG T,LUO Y,et al.Generation and evaluation of an African swine fever virus mutant with deletion of the CD2v and UK genes[J].Vaccines,2020,8(4):763.
• [11] DING M,DANG W,LIU H,et al.Combinational deletions of MGF360-9L and MGF505-7R attenuated highly virulent African swine fever virus and conferred protection against homologous challenge[J].J Virol,2022,96(14):e0032922.
• [12] O?DONNELL V,HOLINKA L G,GIADUE D P,et al.African swine fever virus Georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus[J].J Virol,2015,89(11):6048-6056.
• [13] DING M,DANG W,LIU H,et al.Sequential deletions of interferon inhibitors MGF110-9L and MGF505-7R result in sterile immunity against the Eurasia strain of Africa swine fever[J].J Virol,2022,96(20):e0119222.
• [14] BORCA M V,RAMIREZ-MEDINA E,SILVA E,et al.Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain[J].J Virol,2020,94(7):e02017-19.
• [15] JAING C,ROWLAND R R R,ALLEN J E,et al.Gene expression analysis of whole blood RNA from pigs infected with low and high pathogenic African swine fever viruses[J].Sci Rep,2017,7(1):10115.
• [16] CARRASCOSA A L,BUSTOS M J,DE LEON P.Methods for growing and titrating African swine fever virus:Field and laboratory samples[J].Curr Protoc Cell Biol,2011,53:26.
• [17] REED L J,MUENCH H.A simple method of estimating fifty percent endpoints[J].Am J Epidemiol,1938(3):3.
• [18] ARIAS,MARISA,TORRE D L,et al.Approaches and perspectives for development of African swine fever virus vaccines[J].Vaccines (Basel),2017,5(4):e35.
• [19] ZSAK L,CALER E,LU Z,et al.A nonessential African swine fever virus gene UK is a significant virulence determinant in domestic swine[J].J Virol,1998,72(2):1028-1035.
• [20] AFONSO C L,PICCONE M E,ZAFFUTO K M,et al.African swine fever virus multigene family 360 and 530 genes affect host interferon response[J].J Virol,2004,78(4):1858-1864.
• [21] BORCA M V,O’DONNELL V,HOLINKA L G,et al.The L83L ORF of African swine fever virus strain Georgia encodes for a non-essential gene that interacts with the host protein IL-1β[J].Virus Res,2018,249:116-123.
• [22] GALLARDO C,ELENA G.SáNCHEZ,DANIEL PéREZ-NúEZ,et al.African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses[J].Vaccine,2018,36(19):2694-2704.
• [23] PEDRO J.SáNCHEZ-CORDóN,JABBAR T,BERREZAIE M,et al.Evaluation of protection induced by immunisation of domestic pigs with deletion mutant African swine fever virus BeninDeltaMGF by different doses and routes[J].Vaccine,2018,36(5):707-715.
• [24] ABRAMS C C,GOATLEY L,FISHBOURNE E,et al.Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus[J].Virology,2013,443:99-105.
• [25] MONTEAGUDO P L,LACASTA A,LóPEZ E,et al.BA71ΔCD2:A new recombinant live attenuated African swine fever virus with cross-protective capabilities[J].J Virol,2017,91(21):e01058-17.
• [26] REIS A L,GOATLEY L C,JABBAR T,et al.Deletion of the African swine fever virus gene DP148R does not reduce virus replication in culture but reduces virus virulence in pigs and induces high levels of protection against challenge[J].J Virol,2017,91(24):e01428-17.
• [27] O?DONNELL V,HOLINKA L G,SANFORD B,et al.African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge[J].Virus Res,2016,221:8-14.
• [28] CORREIA S,VENTURA S,PARKHOUSE R M.Identification and utility of innate immune system evasion mechanisms of ASFV[J].Virus Res,2012,173(1):87-100.
• [29] O′DONNELL V,RISATTI G R,HOLINKA L G,et al.Simultaneous deletion of the 9GL and UK genes from the African swine fever virus Georgia 2007 isolate offers increased safety and protection against homologous challenge[J].J Virol,2017,91(1):e01760-16.
• [30] CHEN W,ZHAO D,HE X,et al.A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs[J].Sci China Life Sci,2020,63(5):623-634.
• [31] RAMIREZ-MEDINA E,VUONO E,O?DONNELL V,et al.Differential effect of the deletion of African swine fever virus virulence-associated genes in the induction of attenuation of the highly virulent Georgia strain[J].Viruses,2019,11(7):599.
• [32] GLADUE D P,O?DONNELL V,RAMIREZ-MEDINA E,et al.Deletion of CD2-like (CD2v) and C-type lectin-like (EP153R) genes from African swine fever virus Georgia-Δ9GL abrogates its effectiveness as an experimental vaccine[J].Viruses,2020,12(10):1185.